| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
November 22, 2011 |
|
|
| |
|
|
| |
|
|
|
Center for Professional Innovation & Education (CfPIE), King of Prussia, PA
Feb. 9 & 10, 2012
This course will provide participants with an understanding of drug safety at the investigational stage and during the marketing phase. Adverse event identification and reporting requirements will be addressed, as well as FDA, EMEA, Health Canada and ICH roles in the drug safety process. The course will also discuss international law/regulations, ICH guidelines, Pharmacovigilance, definitions and current regulatory issues.Adverse event reporting requirements specific to the US, Canada, Japan, and Europe will be discussed and compared in detail. Participants will be provided with templates for reporting requirements in each region covered. Multiple exercises are included to reinforce the lecture material. Through the use of various scenarios, participants will learn how to assess and report Adverse Events (AEs) including Serious Adverse Events (SAEs).
|
|
|
|
|
|
|
|
Organized by:
|
|
Center for Professional Innovation & Education |
|
|
Invited Speakers:
|
|
Contact info@cfpie.com for a list of course instructors
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.cfpie.com/showitem.aspx?productid=002&source=hummolgen
|
|
|
E-mail:
|
|
info@cfpie.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|